Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koji Takeuchi

Showing results (71-80 of 216) with videos related to

Pageof 22
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|April 16, 2005
Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in ratsAya Yokota, Masaki Taniguchi, Yuka Takahira, et al.
Digestive Diseases and Sciences|October 17, 2003
Stimulation by capsaicin of duodenal HCO3(-) secretion via afferent neurons and vanilloid receptors in rats: comparison with acid-induced HCO3(-) responseShigeru Kagawa, Masako Aoi, Yoshiaki Kubo, et al.
World Journal of Gastroenterology|January 31, 2002
Stimulation by nizatidine, a histamine H(2)-receptor antagonist, of duodenal HCO(3)(-)secretion in rats:relation to anti-cholinesterase activityKoji Takeuchi, Shoji Kawauchi, Hideo Araki, et al.
Japanese Journal of Pharmacology|February 22, 2002
Protective effect of thiaton, an antispasmodic drug, against indomethacin-induced intestinal damage in ratsTomonori Kunikata, Tohru Miyazawa, Kenji Kanatsu, et al.
Journal of Gastroenterology and Hepatology|April 17, 2004
Mucosal irritative and healing impairment action of risedronate in rat stomachs: comparison with alendronateKenji Kanatsu, Eitaro Aihara, Mituaki Okayama, et al.
Inflammopharmacology|November 2, 2005
A novel gastric lesion model induced in rats by partial gastric vascular ligationTohru Kotani, Toshio Fujimura, Kikuko Amagase, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 2010
Pathogenic importance of cysteinyl leukotrienes in development of gastric lesions induced by ischemia/reperfusion in miceYuka Nakamori, Yoshino Komatsu, Tohru Kotani, et al.
European Journal of Pharmacology|November 29, 2008
The dipeptidyl peptidase-4 inhibitor alogliptin in combination with pioglitazone improves glycemic control, lipid profiles, and increases pancreatic insulin content in ob/ob miceYusuke Moritoh, Koji Takeuchi, Tomoko Asakawa, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 10, 2014
Lubiprostone prevents nonsteroidal anti-inflammatory drug-induced small intestinal damage by suppressing the expression of inflammatory mediators via EP4 receptorsShusaku Hayashi, Naoto Kurata, Aya Yamaguchi, et al.
Journal of Gastroenterology and Hepatology|July 1, 2010
Protective effect of lafutidine, a histamine H2 receptor antagonist, against loxoprofen-induced small intestinal lesions in ratsKikuko Amagase, Akimu Ochi, Tetsuya Sugihara, et al.
Pageof 22

Showing results (71-80 of 216) with videos related to

Sort By:
Pageof 22
The Journal of Pharmacology and Experimental Therapeutics|April 16, 2005
Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in ratsAya Yokota, Masaki Taniguchi, Yuka Takahira, et al.
Digestive Diseases and Sciences|October 17, 2003
Stimulation by capsaicin of duodenal HCO3(-) secretion via afferent neurons and vanilloid receptors in rats: comparison with acid-induced HCO3(-) responseShigeru Kagawa, Masako Aoi, Yoshiaki Kubo, et al.
World Journal of Gastroenterology|January 31, 2002
Stimulation by nizatidine, a histamine H(2)-receptor antagonist, of duodenal HCO(3)(-)secretion in rats:relation to anti-cholinesterase activityKoji Takeuchi, Shoji Kawauchi, Hideo Araki, et al.
Japanese Journal of Pharmacology|February 22, 2002
Protective effect of thiaton, an antispasmodic drug, against indomethacin-induced intestinal damage in ratsTomonori Kunikata, Tohru Miyazawa, Kenji Kanatsu, et al.
Journal of Gastroenterology and Hepatology|April 17, 2004
Mucosal irritative and healing impairment action of risedronate in rat stomachs: comparison with alendronateKenji Kanatsu, Eitaro Aihara, Mituaki Okayama, et al.
Inflammopharmacology|November 2, 2005
A novel gastric lesion model induced in rats by partial gastric vascular ligationTohru Kotani, Toshio Fujimura, Kikuko Amagase, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 2010
Pathogenic importance of cysteinyl leukotrienes in development of gastric lesions induced by ischemia/reperfusion in miceYuka Nakamori, Yoshino Komatsu, Tohru Kotani, et al.
European Journal of Pharmacology|November 29, 2008
The dipeptidyl peptidase-4 inhibitor alogliptin in combination with pioglitazone improves glycemic control, lipid profiles, and increases pancreatic insulin content in ob/ob miceYusuke Moritoh, Koji Takeuchi, Tomoko Asakawa, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 10, 2014
Lubiprostone prevents nonsteroidal anti-inflammatory drug-induced small intestinal damage by suppressing the expression of inflammatory mediators via EP4 receptorsShusaku Hayashi, Naoto Kurata, Aya Yamaguchi, et al.
Journal of Gastroenterology and Hepatology|July 1, 2010
Protective effect of lafutidine, a histamine H2 receptor antagonist, against loxoprofen-induced small intestinal lesions in ratsKikuko Amagase, Akimu Ochi, Tetsuya Sugihara, et al.
Pageof 22